There is no need to reverse-engineer the drug, as its under an expired patent—so all of the processes and techniques used are open and theoretically (if the patent office has done its job right) should be easy for a competitor to reproduce.
this is in fact one of the stated goals of the patent system: a limited monopoly in exchange for the advancement of public knowledge.
this is in fact one of the stated goals of the patent system: a limited monopoly in exchange for the advancement of public knowledge.